Endo Strikes $50M Opioid Deal In NY Amid Trial Tumult
Endo Pharmaceuticals late Thursday announced a $50 million settlement to exit a New York opioid trial that has been thrown into disarray amid allegations the drugmaker and its Arnold & Porter...To view the full article, register now.
Already a subscriber? Click here to view full article